Coronary disease & ACS

Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis

JAMAPublished Pooled analysis of 5 population-based cohort studies

Authors' conclusion

Among women at low ASCVD risk, CAC was present in approximately one-third and was associated with an increased risk of ASCVD and modest improvement in prognostic accuracy compared with traditional risk factors.

Study context

Population
Women with 10-year atherosclerotic CVD (ASCVD) risk <7.5% from 5 population-based cohorts (Dallas Heart, Framingham Heart, Heinz Nixdorf Recall, MESA, Rotterdam); Coronary artery calcium (CAC) scans 1998–2006
Participants
6,739 women5 cohorts
Comparison
CAC >0 vs CAC = 0
Outcome
Incident ASCVD (nonfatal MI, CHD death, stroke)
Follow-up
Median 7.0 to 11.6 years across cohorts
Methodological detailsfixed-effects meta-analysis, multicentre, US, Germany, Netherlands cohorts
  • Fixed-effects meta-analysis
  • Multicentre
  • US, Germany, Netherlands cohorts

Pooled result

As reported in the abstract

Incident ASCVD
CAC presence vs CAC absenceDifference, per 1000 person-years (95% CI)
Incident ASCVD
2.92(2.02–3.83)
CAC presence vs CAC absenceHazard ratio (95% CI)
Multivariable-adjusted
2.04(1.44–2.90)

Further pooled results

Prevalence of CAC

CAC present
36.1%

ASCVD events overall

Total ASCVD events
165
Nonfatal MI
64
Coronary heart disease (CHD) deaths
29
Strokes
72
ASCVD incidence rates across cohorts (per 1000 person-years)
1.5 to 6.0

ASCVD prediction: addition of CAC to traditional risk factors

C statistic, traditional risk factors
0.73 (95% CI 0.69-0.77)
C statistic, with CAC
0.77 (95% CI 0.74-0.81)
Continuous net reclassification improvement (cNRI)
0.20 (95% CI 0.09-0.31)

Original publication

Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis. JAMA. Published 22 November 2016. doi:10.1001/jama.2016.17020

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.